Le Lézard
Classified in: Health
Subjects: RCL, PSF

Updated Food Recall Warning (Allergen) - Minhas Craven brand Pina Colada alcoholic beverage recalled due to undeclared milk


Product photo is available: https://www.inspection.gc.ca/eng/1610145619822/1610145624861

OTTAWA, ON, Jan. 8, 2021 /CNW/ - The food recall warning issued on December 24, 2020, has been updated to include additional product information. This additional information was identified during the Canadian Food Inspection Agency's (CFIA) food safety investigation.

Minhas Sask Ventures Inc. is recalling Minhas Craven brand Pina Colada alcoholic beverage from the marketplace because it contains milk which is not declared on the label. People with an allergy to milk should not consume the recalled product described below.

The following product has been sold in Saskatchewan.

Recalled product

Brand

Product

Size

UPC

Codes

Minhas
Craven

Pina Colada alcoholic beverage

1.75 L

0 62811 11100 9

All codes where milk is not declared on the label

What you should do

Check to see if you have the recalled product in your home. Recalled products should be thrown out or returned to the store where they were purchased.

If you have an allergy to milk, do not consume the recalled product as it may cause a serious or life-threatening reaction.

Background

This recall was triggered by the CFIA's inspection activities. The CFIA is conducting a food safety investigation, which may lead to the recall of other products. If other high-risk products are recalled, the CFIA will notify the public through updated Food Recall Warnings.

The CFIA is verifying that industry is removing the recalled product from the marketplace.

Reactions

There have been no reported reactions associated with the consumption of this product.

SOURCE Canadian Food Inspection Agency (CFIA)


These press releases may also interest you

at 07:32
Duchesnay Pharmaceutical Group (DPG), one of the eight companies across the country chosen to participate in the Government of Canada's Global Hypergrowth Project, is very proud to announce that it has been awarded the Parity Certificationtm by Women...

at 06:30
The global microscopy market is poised for significant growth, expected to reach USD 10.6 billion by 2029 from USD 8.1 billion in 2024, growing at a CAGR of 5.4%. Key drivers include rising cases of chronic diseases necessitating effective...

at 06:25
Genexine (KOSDAQ: 095700), a publicly-listed, clinical-stage Korean biopharmaceutical company committed to the discovery and development of novel biologics for the treatment of serious unmet medical needs, announced a merger with EPD Biotherapeutics...

at 06:03
The IAMStm brand, proudly part of the Mars family of brands, announced today the launch of the IAMStm Puppy Hub and Kitten Hub, two online tools featuring expert knowledge and advice for new and soon-to-be pet parents. Each Hub will bring...

at 06:00
Today, TELUS Health announced a collaboration with Nova Scotia Health (NSH) to enable residents of Nova Scotia to access their primary care information through the YourHealthNS app. This health data interoperability initiative marks the first...

at 05:30
The global Digital Healthcare Market, valued at $220.10 billion in 2024, is on a trajectory of rapid expansion, with projections indicating it will soar to $836.10 billion by 2031, growing at a compound annual growth rate (CAGR) of 21% from 2024 to...



News published on and distributed by: